DOI:
10.1055/s-00000009
American Journal of Perinatology
LinksClose Window
References
Tocilizumab cost effective in reducing COVID-19-related deaths.
PharmacoEcon Outcomes News 2021;
879 (01) 28
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.